Why the study?
Considerable uncertainty persists regarding potential sex differences in post-PCI outcomes among ACS patients due to conflicting results in previous studies.
Does female sex increase the risk of major adverse cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention compared to male sex?
Does female sex increase the risk of major adverse cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention compared to male sex?
Women undergoing percutaneous coronary intervention for acute coronary syndrome face a significantly higher risk of short- and long-term major adverse cardiovascular events and mortality compared to men.
Answers are grounded in this paper and cite their sources.
Women face higher post-PCI adverse event risk than men in ACS; confirms sex disparities warranting targeted strategies in trials and practice.
Background: Percutaneous coronary intervention (PCI) is considered the procedure of choice for patients with acute coronary syndrome (ACS), as it significantly improves cardiovascular outcomes. However, considerable uncertainty persists regarding the potential sex differences in PCI outcomes, due to conflicting results in previous studies. Objectives: This meta-analysis aims to evaluate potential sex-related differences in cardiovascular adverse outcomes after PCI among ACS patients. Methods: The primary outcome was major adverse cardiovascular events (MACE) and its components. Outcomes were examined in various time frames including: short-term (within 1 month after PCI), mid-term (within 1 year), and long-term (within >1 year). A random effects model was used to estimate risk ratios (RR) and 95% CIs. Results: Among 32 trials, at short-term, PCI was associated with a higher risk of MACE (risk ratio [RR]: 1.43; 95% CI: 1.10-1.86), all-cause mortality (RR: 2.51; 95% CI: 1.70-3.71), and myocardial infarction (RR: 1.33; 95% CI: 1.00-1.77) in women compared with men. Over the long-term, women had a higher risk of MACE (RR: 1.11; 95% CI: 1.01-1.22), all-cause mortality (RR: 1.29; 95% CI: 1.17-1.42), and cardiovascular mortality (RR: 1.30; 95% CI: 1.11-1.52), when compared with men. However, the analysis for stroke and repeat revascularization showed no significant difference between the 2 groups in the long- and short-term. Conclusions: In the meta-analysis of PCI-related trials in ACS, women have a higher risk of adverse cardiovascular outcomes compared with men.
No takes yet. Share an insight, caveat, or question.
Shojaei et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: